BUTTPARK 133\40-09
|
- $335 - $1485
- Product name: BUTTPARK 133\40-09
- CAS: 722456-34-0
- MF: C11H8ClN5S
- MW: 277.73
- EINECS:
- MDL Number:MFCD07774509
- Synonyms:3-(4-Chlorobenzyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine-7-thiol;BUTTPARK 133\40-09;7H-1,2,3-Triazolo[4,5-d]pyrimidine-7-thione, 3-[(4-chlorophenyl)methyl]-3,6-dihydro-
3 prices
Selected condition:
Brand
- Chemenu
Package
- 100mg
- 250mg
- 1g
- ManufacturerChemenu
- Product numberCM337829
- Product description3-(4-Chlorobenzyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine-7-thiol 95%+
- Packaging100mg
- Price$335
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM337829
- Product description3-(4-Chlorobenzyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine-7-thiol 95%+
- Packaging250mg
- Price$617
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM337829
- Product description3-(4-Chlorobenzyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine-7-thiol 95%+
- Packaging1g
- Price$1485
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Chemenu | CM337829 | 3-(4-Chlorobenzyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine-7-thiol 95%+ | 100mg | $335 | 2021-12-16 | Buy |
| Chemenu | CM337829 | 3-(4-Chlorobenzyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine-7-thiol 95%+ | 250mg | $617 | 2021-12-16 | Buy |
| Chemenu | CM337829 | 3-(4-Chlorobenzyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine-7-thiol 95%+ | 1g | $1485 | 2021-12-16 | Buy |
Properties
Boiling point :517.6±60.0 °C(Predicted)
Density :1.61±0.1 g/cm3(Predicted)
storage temp. :Store at 0-8 °C
pka :-2.26±0.20(Predicted)
Density :1.61±0.1 g/cm3(Predicted)
storage temp. :Store at 0-8 °C
pka :-2.26±0.20(Predicted)
Safety Information
| Symbol(GHS): |
|
||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | ||||||||||||||||||||||||||||||||
| Hazard statements: |
|
||||||||||||||||||||||||||||||||
| Precautionary statements: |
|




